Price (delayed)
$11.07
Market cap
$1.04B
P/E Ratio
48.13
Dividend/share
N/A
EPS
$0.23
Enterprise value
$1.02B
catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic
Special dividends are included in TTM DPS and yield
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.